FDA Advisors Leave Door Open To Mix and Match COVID-19 Vaccine Boosters

 
• By Sarah Karlin-Smith
  
white open door red walls
Some VRBPAC members felt a small NIH study was enough to permit an EUA for heterologous boosting. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet